Delivery Order SPE2DE24DA010-SPE2D625F9RQ5
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a delivery order valued at $33,000 by the Medical Supply Chain division of the Department of Defense. The contract, designated MITRCLIP and issued on July 25, 2025, utilizes fixed-price pricing with economic price adjustment terms and carries an ultimate completion date of July 30, 2025. The place of performance is located in Santa Clara, California. This delivery order was awarded without a set-aside...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $5,495 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025, with an ultimate completion date of August 4, 2025. This delivery order, which contains no set-aside designation indicating full and open competition, represents a call against a larger indefinite delivery contract vehicle. The work will be performed in Santa Clara, California, and involves the...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract valued at $51.3K by the Medical Supply Chain, a defense-focused federal agency, on July 16, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of July 21, 2025, and will be performed in Santa Clara, California. The contract was awarded under full and open competition with no set-aside designation, indicating Abbott competed against other...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $25,715.85 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025, with an ultimate completion date of August 21, 2025. The contract, identified as GALLANT (4569142750), will be performed in Santa Clara, California, and represents a non-set-aside award made through full and open competition. Abbott Vascular specializes in advanced cardiovascular medical...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order with economic price adjustment totaling $9,500 by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as AVEIR and issued on July 29, 2025, with an ultimate completion date of August 1, 2025, will be performed in Santa Clara, California. This delivery order was awarded without set-aside designation, indicating full and open competition among...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order (Contract No. 4568634478, GALLANT) by the Medical Supply Chain division of the Department of Defense on June 20, 2025, with an ultimate completion date of June 25, 2025. The contract, valued at $30,281.95, carries no set-aside designation, indicating full and open competition. Performance will occur at Abbott's facility in Santa Clara, California. This delivery order represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $8,750 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes a fixed-price pricing structure with economic price adjustment provisions and is not subject to any set-aside designation, indicating full and open competition. The award covers delivery of the AVEIR Leadless Pacemaker to the place...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a major pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The $30,281.95 fixed-price delivery order contract has an ultimate completion date of November 26, 2024. The contract does not include a set-aside designation, indicating full and open competition. Abbott Laboratories Inc., through its Abbott Vascular Inc....
- This federal contract award was made by the Medical Supply Chain, a division of the Defense agency, to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $5,695.00 fixed-price with economic price adjustment delivery order contract is for the provision of cardiovascular medical devices and related services to support federal healthcare systems, particularly the Department of Veterans Affairs (VA) and the Defense Logistics Agency (DLA). The contract has an ultimate...
- This is a delivery order worth $38,665.80 awarded by the Medical Supply Chain, a component of the Defense Logistics Agency, to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract is a firm fixed-price with economic price adjustment and does not have a set-aside designation,...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F9RQ5Delivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $66,000 by the Defense Logistics Agency's Medical Supply Chain on July 31, 2025, with an ultimate completion date of August 5, 2025. The contract, designated as MITRCLIP and issued without set-aside provisions under full and open competition, calls for delivery to Santa Clara, California. This delivery order represents a task order against Abbott's broader federal contract vehicles with the Defense Logistics Agency, which include a substantial $117.1 million Indefinite Delivery Contract for comprehensive procedural packages covering cardiovascular technologies, devices, instrumentation, and accessories. Abbott Vascular Inc. is a critical supplier of advanced cardiovascular medical technologies to federal healthcare systems, specializing in products such as the MitraClip system—a minimally invasive transcatheter solution for mitral valve repair. The fixed-price contract with economic price adjustment protects the government against inflation while ensuring cost certainty for this specialized medical device delivery. Abbott's extensive track record with the Department of Veterans Affairs and Defense Logistics Agency, coupled with its comprehensive support capabilities including 24/7 technical assistance and on-site expertise, positions the company as a key provider of sophisticated cardiovascular solutions across federal healthcare procurement channels.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $66.0k | 7/31/25 |